Literature DB >> 12576818

Superiority of ratio based lymph node staging for bladder cancer.

Harry W Herr1.   

Abstract

PURPOSE: The current study evaluated lymph node staging and the outcome in patients with lymph node positive bladder cancer after radical cystectomy.
MATERIALS AND METHODS: A total of 162 patients with lymph node positive bladder cancer were followed a median of 7.5 years after radical cystectomy and pelvic lymph node dissection for survival and local recurrence. Lymph node disease was stratified by pN stage, the number of positive lymph nodes and the number of positive lymph nodes in relation to the number removed (ratio based pN stage).
RESULTS: A median of 13 lymph nodes (range 2 to 32) was examined, showing an average of 3.3 positive lymph nodes per specimen. An increased number of lymph nodes correlated with the identification of lymph node positive cases. The ratio of the number of positive-to-total number of lymph nodes removed better defined surgical outcome than conventional lymph node staging.
CONCLUSIONS: Ratio based lymph node staging, which reflects the number of lymph nodes examined and the quality of lymph node dissection, was a significant prognostic variable for survival and local control in patients with lymph node positive bladder cancer after radical cystectomy.

Entities:  

Mesh:

Year:  2003        PMID: 12576818     DOI: 10.1097/01.ju.0000032474.22093.06

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  61 in total

1.  Risk stratification of oral cancer patients using a combined prognostic factor including lymph node density and biomarker.

Authors:  Ki-Yeol Kim; In-Ho Cha
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-23       Impact factor: 4.553

2.  Dukes C colorectal cancer: is the metastatic lymph node ratio important?

Authors:  Matthew Thomas; Somita Biswas; Faheez Mohamed; Kandiah Chandrakumaran; Madan Jha; Robert Wilson
Journal:  Int J Colorectal Dis       Date:  2011-11-09       Impact factor: 2.571

3.  Positive Lymph Node Ratio as an Indicator of Prognosis and Local Tumor Clearance in N3 Gastric Cancer.

Authors:  Shuhei Komatsu; Daisuke Ichikawa; Mahito Miyamae; Toshiyuki Kosuga; Kazuma Okamoto; Tomohiro Arita; Hirotaka Konishi; Ryo Morimura; Yasutoshi Murayama; Atsushi Shiozaki; Yoshiaki Kuriu; Hisashi Ikoma; Masayoshi Nakanishi; Hitoshi Fujiwara; Eigo Otsuji
Journal:  J Gastrointest Surg       Date:  2016-06-28       Impact factor: 3.452

Review 4.  The role and extent of pelvic lymphadenectomy in the management of patients with invasive urothelial carcinoma.

Authors:  Seth P Lerner
Journal:  Curr Treat Options Oncol       Date:  2009-06-30

5.  Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer.

Authors:  Chukwumere E Nwogu; Adrienne Groman; Daniel Fahey; Sai Yendamuri; Elisabeth Dexter; Todd L Demmy; Austin Miller; Mary Reid
Journal:  Ann Thorac Surg       Date:  2012-03-20       Impact factor: 4.330

6.  Role of lymphadenectomy for invasive bladder cancer.

Authors:  Faysal A Yafi; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

7.  Lymph Node Metastasis in the Prognosis of Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Jacob A Martin; Richard R P Warner; Anne Aronson; Juan P Wisnivesky; Michelle Kang Kim
Journal:  Pancreas       Date:  2017-10       Impact factor: 3.327

8.  Lymph node ratio improves TNM and Astler-Coller's assessment of colorectal cancer prognosis: an analysis of 761 node positive cases.

Authors:  Renato Costi; Filippo Beggi; Valeria Reggiani; Matteo Riccò; Pellegrino Crafa; Melissa Bersanelli; Francesco Tartamella; Vincenzo Violi; Luigi Roncoroni; Leopoldo Sarli
Journal:  J Gastrointest Surg       Date:  2014-08-05       Impact factor: 3.452

9.  Role of pelvic lymphadenectomy in the treatment of bladder cancer: a mini review.

Authors:  Ja Hyeon Ku
Journal:  Korean J Urol       Date:  2010-06-21

10.  Treatment of locally advanced and metastatic bladder cancer.

Authors:  Makarand V Khochikar
Journal:  Indian J Urol       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.